Study S002390

Evaluation of Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes: A Multicenter CDM-Based Retrospective Cohort Study With Prospective AI-ECG Validation

ClinicalTrials.gov record

Registration

Registration: NCT07770737
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-09
Primary completion: 2027-12-31
Lead sponsor: Dongtan Sacred Heart Hospital
Conditions: Type 2 Diabetes Mellitus (T2DM); Cardiovascular Diseases; Stage B Heart Failure
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Time to First Atherosclerotic Cardiovascular Disease Composite Event [From the index date until the first occurrence of acute myocardial infarction or ischemic stroke, loss to follow-up, death, or the end of available database records, whichever occurs first, assessed up to 12 years]
Time to First Hospitalization for Heart Failure [From the index date until the first hospitalization for heart failure, loss to follow-up, death, or the end of available database records, whichever occurs first, assessed up to 12 years]
Change in Echocardiographic Global Longitudinal Strain [Baseline and 6 months after SGLT2 inhibitor initiation]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.